報價延遲最少15分鐘:2026/04/26 08:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
21.18 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.46/-1.17
|
|
企業價值
818.77M
|
| 資產負債 |
|
每股賬面淨值
4.10
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
89.06M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal. |
